Loading organizations...
§ Private Profile · Chattanooga, TN, USA
Develops catheter technologies for vascular diseases, with a focus on the Occlusion Perfusion Catheter for PAD.
Founded in 2008 by Paul Fitzpatrick and Rex Teeslink, Advanced Catheter Therapies is a Chattanooga, Tennessee medical device company developing innovative technologies for vascular diseases like peripheral arterial disease. The enterprise focuses on its patented Occlusion Perfusion Catheter, which allows physicians to temporarily isolate specific blood vessel sections to deliver targeted therapeutic agents directly to diseased tissue. The organization has secured over 5 million dollars in early stage funding, including a large Series A round, while accumulating 24 issued patents and three FDA clearances. Following the conclusion of a major licensing agreement with Toray Industries, the firm is currently seeking an additional 20 to 30 million dollars to fund further combination device development. This ongoing commercialization and research effort is being led by the original founders alongside key company executives Dirk Hoyns and Kevin Dye.
Advanced Catheter Therapies has raised $10.5M across 3 funding rounds.
Advanced Catheter Therapies has raised $10.5M in total across 3 funding rounds.
Advanced Catheter Therapies has raised $10.5M across 3 funding rounds. Most recently, it raised $4.5M Series B in March 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 17, 2015 | $4.5M Series B | Shigeo Fujimori | — | Announced |
| Jun 5, 2013 | $3M Series B | — | — | Announced |
| Sep 29, 2011 | $3M Series A | — | ACT I Investments, Chattanooga Neighborhood Enterprise, Chattanooga Renaissance Fund, Maclellan Foundation, Medical Device Development Group | Announced |
Advanced Catheter Therapies has raised $10.5M in total across 3 funding rounds.
Advanced Catheter Therapies's investors include Shigeo Fujimori, ACT I Investments, Chattanooga Neighborhood Enterprise, Chattanooga Renaissance Fund, Maclellan Foundation, Medical Device Development Group.